These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 987200)

  • 1. [Studies on lysergic acid diethylamide and related compounds. IV. Syntheses of various amide derivatives of norlysergic acid and related compounds].
    Niwaguchi T; Nakahara Y; Ishii H
    Yakugaku Zasshi; 1976 May; 96(5):673-8. PubMed ID: 987200
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on lysergic acid diethylamide and related compounds. Part 8. Structural identification of new metabolites of lysergic acid diethylamide obtained by microbial transformation using Streptomyces roseochromogenes.
    Ishii H; Niwaguchi T; Nakahara Y; Hayashi M
    J Chem Soc Perkin 1; 1980; 4():902-5. PubMed ID: 7190156
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis and LSD-like discriminative stimulus properties in a series of N(6)-alkyl norlysergic acid N,N-diethylamide derivatives.
    Hoffman AJ; Nichols DE
    J Med Chem; 1985 Sep; 28(9):1252-5. PubMed ID: 4032428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Synthesis of structural analogs of LSD].
    Mravec D; Kalamár J; Proksa B; Horák F
    Cesk Farm; 1975 Apr; 24(3):110-5. PubMed ID: 1157105
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on lysergic acid diethylamide and related compounds. 3. Improvement of amidation of lysergic acid (author's transl)].
    Nakahara Y; Niwaguchi T
    Yakugaku Zasshi; 1974 Mar; 94(3):407-12. PubMed ID: 4859118
    [No Abstract]   [Full Text] [Related]  

  • 6. Lysergic acid diethylamide (LSD-25) antagonists. II. Development of tolerance in man to LSD-25 by prior administration of MLD-41 (1-methyl-d-lysergic acid diethylamide).
    ABRAMSON HA; SKLAROFSKY B; BARON MO; FREMONT-SMITH N
    AMA Arch Neurol Psychiatry; 1958 Feb; 79(2):201-7. PubMed ID: 13497364
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of d-lysergic acid diethylamide and related compounds on melanophores].
    BERDE B; CERLETTI A
    Helv Physiol Pharmacol Acta; 1956; 14(3):325-33. PubMed ID: 13405353
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative study on the serotonin antagonism of amide derivatives of lysergic acid and of ergot alkaloids.
    CERLETTI A; DOEPFNER W
    J Pharmacol Exp Ther; 1958 Jan; 122(1):124-36. PubMed ID: 13502837
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on the pharmacology of D-lysergic acid cycloalkylamides.
    VOTAVA Z; PODVALOVA I; SEMONSKY M
    Arch Int Pharmacodyn Ther; 1958 May; 115(1-2):114-30. PubMed ID: 13545891
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis of compounds related to lysergic acid.
    Craig JC
    Psychopharmacol Bull; 1969 Apr; 5(2):21-2. PubMed ID: 5347489
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of a new compound, UML-491 (1-methyl-D-lysergic acid butanolamide), in the prevention of various types of headache.
    GRAHAM JR
    N Engl J Med; 1960 Dec; 263():1273-7. PubMed ID: 13707731
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on lysergic acid diethylamide and related compounds. VII. Microbial transformation of lysergic acid diethylamide and related compounds.
    Ishii H; Hayashi M; Niwaguchi T; Nakahara Y
    Chem Pharm Bull (Tokyo); 1979 Jul; 27(7):1570-5. PubMed ID: 540347
    [No Abstract]   [Full Text] [Related]  

  • 13. Binding and circular dichroism studies on interactions of lysergic acid diethylamide with deoxyribonucleic acid.
    Bush CA; Pesce A; Gaizutis M; Nair V
    Mol Pharmacol; 1972 Jan; 8(1):104-9. PubMed ID: 5061517
    [No Abstract]   [Full Text] [Related]  

  • 14. Separation of D-lysergic acid diethylamide derivatives using micellar electrokinetic capillary chromatography.
    Djordjevic MN; Fitzpatrick F; Houdiere F
    Electrophoresis; 2000 Mar; 21(4):724-8. PubMed ID: 10733212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships between chemical structure and psychoses with the use of psychotoxic substances; comparative pharmacopsychiatric analysis: a new research method.
    SOLMS H
    J Clin Exp Psychopathol; 1956; 17(4):429-33. PubMed ID: 13406032
    [No Abstract]   [Full Text] [Related]  

  • 16. Structural analogs of lysergic acid.
    Campaigne E; Knapp DR
    J Pharm Sci; 1971 Jun; 60(6):809-14. PubMed ID: 4942861
    [No Abstract]   [Full Text] [Related]  

  • 17. Lysergic acid diethylamide (LSD-25). XXXI. Comparison by questionnaire of psychotomimetic activity of congeners on normal subjects and drug addicts.
    ABRAMSON HA
    J Ment Sci; 1960 Jul; 106():1120-3. PubMed ID: 13681136
    [No Abstract]   [Full Text] [Related]  

  • 18. Psychotomimetic drugs; chemical and pharmacological aspects.
    HOFMANN A
    Acta Physiol Pharmacol Neerl; 1959 Jun; 8():240-58. PubMed ID: 13852489
    [No Abstract]   [Full Text] [Related]  

  • 19. New synthesis and characterization of (+)-lysergic acid diethylamide (LSD) derivatives and the development of a microparticle-based immunoassay for the detection of LSD and its metabolites.
    Li Z; Goc-Szkutnicka K; McNally AJ; Pilcher I; Polakowski S; Vitone S; Wu RS; Salamone SJ
    Bioconjug Chem; 1997; 8(6):896-905. PubMed ID: 9404664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Protective action of lysergic acid ethylamide (LAE-32) on behavior changes & on histological lesions of the central nervous system induced in mice by chronic treatment with 5-hydroxytryptamine].
    SORIANI S; FAVALE E
    Sist Nerv; 1959; 11(1):13-21. PubMed ID: 13659105
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.